Description
Dr. Jung-Mo Ahn, Associate Professor of Chemistry, University of Texas at Dallas
September 14, 2022
In this episode, we discuss the use of small molecules as targeted treatments to interrupt the regulatory pathways responsible for cancer growth, neurodegenerative diseases, and other conditions, with relatively minimal off-target effects.
Dr. Adam Leman, Lead Scientist, Fermentation, Good Food Institute
December 19, 2023
In this episode, we discuss the convergence of fermentation, perhaps the world's oldest biotechnology, with modern advancements in molecular biology to produce non-animal proteins as a sustainable food source....
Published 04/08/24